SCHEMBL3080315

SCHEMBL3080315

COC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCC(O)Cc1ccccc1-3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.43
PRKCA P17252 1/20 0.42
MMP12 P39900 1/20 0.42
NR1I2 O75469 3/20 0.41
NPSR1 Q6W5P4 3/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ATM Q13315 1/20 0.38
MTNR1A P48039 2/20 0.37
MTNR1B P49286 2/20 0.37
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36
OGFRL1 Q5TC84 1/20 0.36
CNR2 P34972 1/20 0.36
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3565283 0.92 PRKCA (0.46) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL772587 0.91 SCN9A (0.47) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL771196 0.88 SCN9A (0.49) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL3580592 0.87 SCN9A (0.44) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL4823223 0.86 NR1I2 (0.47) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL13941052 0.85 PRKCA (0.46) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL12429623 0.85 SCN9A (0.43) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL3572572 0.85 PRKCA (0.46) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL13791919 0.84 PRKCA (0.45) SCN9APRKCAMMP12NR1I2NPSR1
SCHEMBL4829981 0.84 PRKCA (0.47) SCN9APRKCAMMP12NR1I2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795247-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-14 US disclosed
EP-1807403-A2 TETRACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2007-07-18 EP disclosed
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHEDI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IRMB) (IT) 2006-05-11 US disclosed
WO-2006046030-A2 TETRACYCLIC INDOLE DERIVATIVES AS ANTIVIRAL AGENTS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents IDO1, ZC3HAV1, IDO2 SCN9A 3788/4885PRKCA 3874/4885MMP12 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.